31 research outputs found

    Photometric Properties of Kiso Ultraviolet-Excess Galaxies in the Lynx-Ursa Major Region

    Get PDF
    We have performed a systematic study of several regions in the sky where the number of galaxies exhibiting star formation (SF) activity is greater than average. We used Kiso ultraviolet-excess galaxies (KUGs) as our SF-enhanced sample. By statistically comparing the KUG and non-KUG distributions, we discovered four KUG-rich regions with a size of 10×10\sim 10^\circ \times 10^\circ. One of these regions corresponds spatially to a filament of length 60h1\sim 60 h^{-1} Mpc in the Lynx-Ursa Major region (α9h10h,δ4248\alpha \sim 9^{\rm h} - 10^{\rm h}, \delta \sim 42^\circ - 48^\circ). We call this ``the Lynx-Ursa Major (LUM) filament''. We obtained V(RI)CV(RI)_{\rm C} surface photometry of 11 of the KUGs in the LUM filament and used these to investigate the integrated colors, distribution of SF regions, morphologies, and local environments. We found that these KUGs consist of distorted spiral galaxies and compact galaxies with blue colors. Their star formation occurs in the entire disk, and is not confined to just the central regions. The colors of the SF regions imply that active star formation in the spiral galaxies occurred 107810^{7 - 8} yr ago, while that of the compact objects occurred 106710^{6-7} yr ago. Though the photometric characteristics of these KUGs are similar to those of interacting galaxies or mergers, most of these KUGs do not show direct evidence of merger processes.Comment: 39 pages LaTeX, using aasms4.sty, 20 figures, ApJS accepted. The Title of the previous one was truncated by the author's mistake, and is corrected. Main body of the paper is unchange

    A search for steep spectrum radio relics and halos with the GMRT

    Full text link
    Context: Diffuse radio emission, in the form of radio halos and relics, traces regions in clusters with shocks or turbulence, probably produced by cluster mergers. Some models of diffuse radio emission in clusters indicate that virtually all clusters should contain diffuse radio sources with a steep spectrum. External accretion shocks associated with filamentary structures of galaxies could also accelerate electrons to relativistic energies and hence produce diffuse synchrotron emitting regions. Here we report on Giant Metrewave Radio Telescope (GMRT) observations of a sample of steep spectrum sources from the 74 MHz VLSS survey. These sources are diffuse and not associated with nearby galaxies. Aims: The main aim of the observations is to search for diffuse radio emission associated with galaxy clusters or the cosmic web. Methods: We carried out GMRT 610 MHz continuum observations of unidentified diffuse steep spectrum sources. Results: We have constructed a sample of diffuse steep spectrum sources, selected from the 74 MHz VLSS survey. We identified eight diffuse radio sources probably all located in clusters. We found five radio relics, one cluster with a giant radio halo and a radio relic, and one radio mini-halo. By complementing our observations with measurements from the literature we find correlations between the physical size of relics and the spectral index, in the sense that smaller relics have steeper spectra. Furthermore, larger relics are mostly located in the outskirts of clusters while smaller relics are located closer to the cluster center.Comment: 20 pages, 26 figures, accepted for publication in A&A on October 7, 200

    Quiescent Isolation: The Extremely Extended HI Halo of the Optically Compact Dwarf Galaxy ADBS 113845+2008

    Full text link
    We present new optical imaging and spectroscopy and HI spectral line imaging of the dwarf galaxy ADBS 113845+2008 (hereafter ADBS 1138). This metal-poor (Z~30% Z_Sun), "post-starburst" system has one of the most compact stellar distributions known in any galaxy to date (B-band exponential scale length =0.57 kpc). In stark contrast to the compact stellar component, the neutral gas is extremely extended; HI is detected to a radial distance of ~25 kpc at the 10^19 cm^-2 level (>44 B-band scale lengths). Comparing to measurements of similar "giant disk" dwarf galaxies in the literature, ADBS 1138 has the largest known HI-to-optical size ratio. The stellar component is located near the center of a broken ring of HI that is ~15 kpc in diameter; column densities peak in this structure at the ~3.5x10^20 cm^-2 level. At the center of this ring, in a region of comparatively low HI column density, we find ongoing star formation traced by H alpha emission. We sample the rotation curve to the point of turn over; this constrains the size of the dark matter halo of the galaxy, which outweighs the luminous component (stars + gas) by at least a factor of 15. To explain these enigmatic properties, we examine "inside-out" and "outside-in" evolutionary scenarios. Calculations of star formation energetics indicate that "feedback" from concentrated star formation is not capable of producing the ring structure; we posit that this is a system where the large HI disk is evolving in quiescent isolation. In a global sense, this system is exceedingly inefficient at converting neutral gas into stars.Comment: Astrophysical Journal, in pres

    The Second Byurakan Survey Galaxies. I. The Optical Database

    Full text link
    A database for the entire catalog of the Second Byurakan Survey (SBS) galaxies is presented. It contains new measurements of their optical parameters and additional information taken from the literature and other databases. The measurements were made using Ipg(near-infrared), Fpg(red) and Jpg(blue) band images from photographic sky survey plates obtained by the Palomar Schmidt telescope and extracted from the STScI Digital Sky Survey (DSS). The database provides accurate coordinates, morphological type, spectral and activity classes, apparent magnitudes and diameters, axial ratios, and position angles, as well as number counts of neighboring objects in a circle of radius 50 kpc. The total number of individual SBS objects in the database is now 1676. The 188 Markarian galaxies which were re-discovered by SBS are not included in this database. We also include redshifts that are now available for 1576 SBS objects, as well as 2MASS infrared magnitudes for 1117 SBS galaxies.Comment: 13 pages, 1 figure, 1 tabl

    Where are the Stars in Dark Galaxies?

    No full text

    A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)

    Get PDF
    Purpose: A high proportion of patients with wild-type EGFR non-small cell lung cancer (NSCLC) receive third-line therapy and beyond, with no prospective randomized trials addressing the issue. This study aimed to select the most suitable regimen as a third- or fourth-line therapy for wild-type EGFR NSCLC. Methods: This multicenter, randomized phase II study in Japan included patients with recurrent or advanced NSCLC with wild-type or unknown EGFR, who progressed after two or three previous chemotherapies. The patients were randomly assigned to erlotinib (150 mg/day, days 1-21) or S-1 (80-120 mg/day, days 1-14) every 3 weeks until disease progression or unacceptable toxicity. The primary endpoint was disease control rate (DCR). The secondary endpoints included overall survival (OS), progression-free survival (PFS), objective response rate (ORR), toxicity, and quality of life (QOL). Results: From 2011 to 2016, 37 patients were randomly assigned to receive erlotinib (E arm, n = 19) and S-1 (S arm, n = 18). This study was terminated prematurely because of poor patient accrual. DCR/ORR were 42.1%/15.8% in the E arm and 66.7%/16.7% in the S arm. Median PFS/OS were 1.6 months/8.0 months in the E arm and 3.3 months/12.2 months in the S arm. In both groups, the most commonly reported grade 3-4 toxicities were fatigue, anorexia, and nausea. One grade 5 pneumonitis occurred in the S arm. No significant difference was seen in QOL. Conclusions: S-1 as a third- or fourth-line therapy for wild-type EGFR NSCLC showed numerically better clinical outcomes than erlotinib. Clinical trial registration no. UMIN000005308
    corecore